SurGenTec Gains 510(k) for TiLink-L SI Joint Fusion

SurGenTec TiLink-L Sacroiliac Joint Fusion

SurGenTec was granted FDA 510(k) clearance to market their proprietary TiLink-L Sacroiliac Joint Fusion System. The device may be implanted from a lateral or posterior/oblique approach and uses unique surface technology to optimize bone growth. This implant will be SurGenTec’s inaugural “First Implant in the Sacroiliac Family of Products.”
...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0